日本抗生物質市場レポート作用機序別(細胞壁合成阻害剤、タンパク質合成阻害剤、DNA合成阻害剤、RNA合成阻害剤、マイコール酸阻害剤、その他)、薬剤クラス別(セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、アミノグリコシド、その他)、活性スペクトル(広域抗生物質、狭域抗生物質)、投与経路(経口、非経口、局所、その他)、エンドユーザー(病院、専門クリニック、その他)、地域 2025-2033

日本抗生物質市場レポート作用機序別(細胞壁合成阻害剤、タンパク質合成阻害剤、DNA合成阻害剤、RNA合成阻害剤、マイコール酸阻害剤、その他)、薬剤クラス別(セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、アミノグリコシド、その他)、活性スペクトル(広域抗生物質、狭域抗生物質)、投与経路(経口、非経口、局所、その他)、エンドユーザー(病院、専門クリニック、その他)、地域 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A27857

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Antibiotics Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   Japan Antibiotics Market Landscape
    5.1    Historical and Current Market Trends (​2019-2024​)
    5.2    Market Forecast (​2025-2033​)
6   Japan Antibiotics Market - Breakup by Action Mechanism
    6.1    Cell Wall Synthesis Inhibitors
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (​2019-2024​)
        6.1.3 Market Forecast (​2025-2033​)
    6.2    Protein Synthesis Inhibitors
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (​2019-2024​)
        6.2.3 Market Forecast (​2025-2033​)
    6.3    DNA Synthesis Inhibitors
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (​2019-2024​)
        6.3.3 Market Forecast (​2025-2033​)
    6.4    RNA Synthesis Inhibitors
        6.4.1 Overview
        6.4.2 Historical and Current Market Trends (​2019-2024​)
        6.4.3 Market Forecast (​2025-2033​)
    6.5    Mycolic Acid Inhibitors
        6.5.1 Overview
        6.5.2 Historical and Current Market Trends (​2019-2024​)
        6.5.3 Market Forecast (​2025-2033​)
    6.6    Others
        6.6.1 Historical and Current Market Trends (​2019-2024​)
        6.6.2 Market Forecast (​2025-2033​)
7   Japan Antibiotics Market - Breakup by Drug Class
    7.1    Cephalosporin
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (​2019-2024​)
        7.1.3 Market Forecast (​2025-2033​)
    7.2    Penicillin
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (​2019-2024​)
        7.2.3 Market Forecast (​2025-2033​)
    7.3    Fluoroquinolone
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (​2019-2024​)
        7.3.3 Market Forecast (​2025-2033​)
    7.4    Macrolide
        7.4.1 Overview
        7.4.2 Historical and Current Market Trends (​2019-2024​)
        7.4.3 Market Forecast (​2025-2033​)
    7.5    Carbapenem
        7.5.1 Overview
        7.5.2 Historical and Current Market Trends (​2019-2024​)
        7.5.3 Market Forecast (​2025-2033​)
    7.6    Aminoglycoside
        7.6.1 Overview
        7.6.2 Historical and Current Market Trends (​2019-2024​)
        7.6.3 Market Forecast (​2025-2033​)
    7.7    Others
        7.7.1 Historical and Current Market Trends (​2019-2024​)
        7.7.2 Market Forecast (​2025-2033​)
8   Japan Antibiotics Market - Breakup by Spectrum of Activity
    8.1    Broad-Spectrum Antibiotics
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (​2019-2024​)
        8.1.3 Market Forecast (​2025-2033​)
    8.2    Narrow-Spectrum Antibiotics
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (​2019-2024​)
        8.2.3 Market Forecast (​2025-2033​)
9   Japan Antibiotics Market - Breakup by Route of Administration
    9.1    Oral
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (​2019-2024​)
        9.1.3 Market Forecast (​2025-2033​)
    9.2    Parenteral
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (​2019-2024​)
        9.2.3 Market Forecast (​2025-2033​)
    9.3    Topical
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (​2019-2024​)
        9.3.3 Market Forecast (​2025-2033​)
    9.4    Others
        9.4.1 Historical and Current Market Trends (​2019-2024​)
        9.4.2 Market Forecast (​2025-2033​)
10  Japan Antibiotics Market - Breakup by End User
    10.1    Hospitals
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (​2019-2024​)
        10.1.3 Market Forecast (​2025-2033​)
    10.2    Specialty Clinics
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (​2019-2024​)
        10.2.3 Market Forecast (​2025-2033​)
    10.3    Others
        10.3.1 Historical and Current Market Trends (​2019-2024​)
        10.3.2 Market Forecast (​2025-2033​)
11  Japan Antibiotics Market – Breakup by Region
    11.1    Kanto Region
        11.1.1 Overview
        11.1.2 Historical and Current Market Trends (​2019-2024​)
        11.1.3 Market Breakup by Action Mechanism
        11.1.4 Market Breakup by Drug Class
        11.1.5 Market Breakup by Spectrum of Activity
        11.1.6 Market Breakup by Route of Administration
        11.1.7 Market Breakup by End User
        11.1.8 Key Players
        11.1.9 Market Forecast (​2025-2033​)
    11.2    Kansai/Kinki Region
        11.2.1 Overview
        11.2.2 Historical and Current Market Trends (​2019-2024​)
        11.2.3 Market Breakup by Action Mechanism
        11.2.4 Market Breakup by Drug Class
        11.2.5 Market Breakup by Spectrum of Activity
        11.2.6 Market Breakup by Route of Administration
        11.2.7 Market Breakup by End User
        11.2.8 Key Players
        11.2.9 Market Forecast (​2025-2033​)
    11.3    Central/ Chubu Region
        11.3.1 Overview
        11.3.2 Historical and Current Market Trends (​2019-2024​)
        11.3.3 Market Breakup by Action Mechanism
        11.3.4 Market Breakup by Drug Class
        11.3.5 Market Breakup by Spectrum of Activity
        11.3.6 Market Breakup by Route of Administration
        11.3.7 Market Breakup by End User
        11.3.8 Key Players
        11.3.9 Market Forecast (​2025-2033​)
    11.4    Kyushu-Okinawa Region
        11.4.1 Overview
        11.4.2 Historical and Current Market Trends (​2019-2024​)
        11.4.3 Market Breakup by Action Mechanism
        11.4.4 Market Breakup by Drug Class
        11.4.5 Market Breakup by Spectrum of Activity
        11.4.6 Market Breakup by Route of Administration
        11.4.7 Market Breakup by End User
        11.4.8 Key Players
        11.4.9 Market Forecast (​2025-2033​)
    11.5    Tohoku Region
        11.5.1 Overview
        11.5.2 Historical and Current Market Trends (​2019-2024​)
        11.5.3 Market Breakup by Action Mechanism
        11.5.4 Market Breakup by Drug Class
        11.5.5 Market Breakup by Spectrum of Activity
        11.5.6 Market Breakup by Route of Administration
        11.5.7 Market Breakup by End User
        11.5.8 Key Players
        11.5.9 Market Forecast (​2025-2033​)
    11.6    Chugoku Region
        11.6.1 Overview
        11.6.2 Historical and Current Market Trends (​2019-2024​)
        11.6.3 Market Breakup by Action Mechanism
        11.6.4 Market Breakup by Drug Class
        11.6.5 Market Breakup by Spectrum of Activity
        11.6.6 Market Breakup by Route of Administration
        11.6.7 Market Breakup by End User
        11.6.8 Key Players
        11.6.9 Market Forecast (​2025-2033​)
    11.7    Hokkaido Region
        11.7.1 Overview
        11.7.2 Historical and Current Market Trends (​2019-2024​)
        11.7.3 Market Breakup by Action Mechanism
        11.7.4 Market Breakup by Drug Class
        11.7.5 Market Breakup by Spectrum of Activity
        11.7.6 Market Breakup by Route of Administration
        11.7.7 Market Breakup by End User
        11.7.8 Key Players
        11.7.9 Market Forecast (​2025-2033​)
    11.8    Shikoku Region
        11.8.1 Overview
        11.8.2 Historical and Current Market Trends (​2019-2024​)
        11.8.3 Market Breakup by Action Mechanism
        11.8.4 Market Breakup by Drug Class
        11.8.5 Market Breakup by Spectrum of Activity
        11.8.6 Market Breakup by Route of Administration
        11.8.7 Market Breakup by End User
        11.8.8 Key Players
        11.8.9 Market Forecast (​2025-2033​)
12  Japan Antibiotics Market – Competitive Landscape
    12.1    Overview
    12.2    Market Structure
    12.3    Market Player Positioning
    12.4    Top Winning Strategies
    12.5    Competitive Dashboard
    12.6    Company Evaluation Quadrant
13  Profiles of Key Players
    13.1    Company A 
        13.1.1 Business Overview
        13.1.2 Product Portfolio
        13.1.3 Business Strategies
        13.1.4 SWOT Analysis
        13.1.5 Major News and Events
    13.2    Company B
        13.2.1 Business Overview
        13.2.2 Product Portfolio
        13.2.3 Business Strategies
        13.2.4 SWOT Analysis
        13.2.5 Major News and Events
    13.3    Company C
        13.3.1 Business Overview
        13.3.2 Product Portfolio
        13.3.3 Business Strategies
        13.3.4 SWOT Analysis
        13.3.5 Major News and Events
    13.4    Company D 
        13.4.1 Business Overview
        13.4.2 Product Portfolio
        13.4.3 Business Strategies
        13.4.4 SWOT Analysis
        13.4.5 Major News and Events
    13.5    Company E
        13.5.1 Business Overview
        13.5.2 Product Portfolio
        13.5.3 Business Strategies
        13.5.4 SWOT Analysis
        13.5.5 Major News and Events    

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

14  Japan Antibiotics Market - Industry Analysis
    14.1    Drivers, Restraints, and Opportunities
        14.1.1 Overview
        14.1.2 Drivers
        14.1.3 Restraints
        14.1.4 Opportunities
    14.2   Porters Five Forces Analysis
        14.2.1 Overview
        14.2.2 Bargaining Power of Buyers
        14.2.3 Bargaining Power of Suppliers
        14.2.4 Degree of Competition
        14.2.5 Threat of New Entrants
        14.2.6 Threat of Substitutes
    14.3    Value Chain Analysis
15  Appendix

日本抗生物質市場レポート作用機序別(細胞壁合成阻害剤、タンパク質合成阻害剤、DNA合成阻害剤、RNA合成阻害剤、マイコール酸阻害剤、その他)、薬剤クラス別(セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、アミノグリコシド、その他)、活性スペクトル(広域抗生物質、狭域抗生物質)、投与経路(経口、非経口、局所、その他)、エンドユーザー(病院、専門クリニック、その他)、地域 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials